Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New PKD inhibitor CRT-0066101 inhibits pancreatic cell growth

May 27, 2010

DMC recommends continued analysis of phase III deforolimus data

May 26, 2010

Pro-Pharmaceuticals plans phase III trial of Davanat

May 26, 2010

NGR-hTNF cleared to enter phase III mesothelioma trial in U.S.

May 26, 2010

Genentech identifies new Janus kinase inhibitors

May 26, 2010

Deciphera claims novel protein kinase inhibitors

May 26, 2010

Enrollment complete in phase II brentuximab vedotin trial in ALCL

May 25, 2010

Bayer Schering Pharma claims new MEK 1 inhibitors

May 25, 2010

Increased IGFBP-7 expression reduces breast cancer growth

May 25, 2010

GAP-107B8 active against ovarian cancer

May 21, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...